Postoperative modulation of central nervous system prostaglandin E2 by cyclooxygenase inhibitors after vascular surgery (Retraction in: Anesthesiology (2009) 110:3 (689))

Anesthesiology

Volumn 104, Issue 3, 2006, Pages 411-416

  Reuben, Scott S ^a   Buvanendran, Asokumar ^b   Kroin, Jeffrey S ^b   Steinberg, Robert B ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CYCLOOXYGENASE 2 INHIBITOR; DOLASETRON MESILATE; FENTANYL; KETOROLAC; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PARECOXIB; PLACEBO; PROPOFOL; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGED; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; HUMAN; LEG REVASCULARIZATION; MALE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; THROMBECTOMY; TREATMENT OUTCOME; VASCULAR SURGERY; ARTICLE; BIOSYNTHESIS; CEREBROSPINAL FLUID; LEG; METABOLISM; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING;

AGED; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; VASCULAR SURGICAL PROCEDURES;

EID: 33645511269     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200603000-00006     Document Type: Conference Paper

References (43)

1. Breslow MJ, Parker SD, Frank SM, Norris EJ, Yates H, Raff H, Rock P, Christopherson R, Rosenfeld BA, Beattie C: Determinants of catecholamine and cortisol responses to lower extremity revascularization. ANESTHESIOLOGY 1993; 79:1202-9
2. Kehlet H, Dahl JB: Anaesthesia, surgery and challenges in postoperative recovery. Lancet 2003; 362:1921-8
3. Gerritsen ME, Cheli CD: Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells. J Clin Invest 1983; 72:1658-71
4. Samad TA, Sapirstein A, Woolf CJ: Prostanoids and pain: Unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 2002; 8:390-6
5. Giuliano F, Warner TD: Origins of prostaglandins E2: Involvement of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. JPET 2002; 102:1001-6
6. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M: Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996; 390:165-9
7. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ: Interleukin-1beta mediated induction of COX-2 in the CNS contributes inflammatory pain hypersensitivity. Nature 2001; 410:471-5
8. Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC: Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. JPET 1997; 283:1069-75
9. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC: Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci 1998; 95:13313-8
10. McCleskey EW, Gold MS: Ions channels of nociception. Annu Rev Physiol 1999; 61:835-56
11. Kroin JS, Ling ZD, Buvanendran A, Tuman KJ: Upregulation of spinal cyclooxygenase-2 in rats after surgical incision. ANESTHESIOLOGY 2004; 100:364-9
12. Zhu XY, Conklin D, Eisenach JC: Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain 2003; 104:15-23
13. Zhu XY, Conklin DR, Eisenach JC: Preoperative inhibition of cyclooxygenase-1 in the spinal cord reduces postoperative pain. Anesth Analg 2005; 100:1390-3
14. 2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. ANESTHESIOLOGY 2006; 104:403-10
15. Ek M, Engblom D, Saha S, Blomqvist A, Jakobsson PJ, Ericsson-Dahlstran A: Pathway across the blood-brain barrier. Nature 2001; 410:430-1
16. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC: The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001; 21:5847-53
17. Sang N, Zhang J, Marcheselli V, Barzan NG, Chen C: Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J Neurosci 2005; 25:9858-70
18. 2α. in rats. JPET 1992; 262:1110-20
19. Tang J, Li S, White PF, Chen X, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E: Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. ANESTHESIOLOGY 2002; 96:1305-9
20. Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T: Epidural anesthesia and analgesia in high-risk surgical patients. ANESTHESIOLOGY 1987; 66:729-36
21. Tuman KJ, McCarthy RJ, March RJ, Delaria GA, Patel RV, Ivankovich AD: Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth Analg 1991; 73:696-704
22. Bikhazi GB, Snabes MC, Bajwa ZH, Davis DJ, LeComte D, Traylor L, Hubbard RC: A clinical trial demonstrating the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy. Am J Obst Gynecol 2004; 191:1183-91
23. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A 1999; 96:7563-8
24. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G: Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 2001; 79:777-86
25. Rice ASC, Lloyd J, Bullingham RES, O'Sullivan G: Ketorolac penetration into the cerebrospinal fluid of humans. J Clin Anesth 1993; 5:459-62
26. Dembo G, Park SB, Kharasch ED: Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. ANESTHESIOLOGY 2005; 102:409-15
27. Bartfai T: Telling the brain about pain. Nature 2001; 410:425-6
28. Hayball PJ, Wrobel J, Tamblyn JG, Nation RL: The pharmacokinetics of ketorolac enatitiomers following intramuscular administration of the racemate. Br J Clin Pharmacol 1994; 37:75-8
29. Karim A, Laurent A, Slater ME, Kuss ME, Qian J, Crosby-Sessoms SL, Hubbard RC: A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. J Clin Pharmacol 2001; 41:1111-9
30. O'Hanlan JJ, Muldoon T, Lowry D, McCleane G: Improved postoperative analgesia with preoperative piroxicam. Can J Anaesth 1996; 43:97-101
31. Colbert ST, O'Hanlon DM, McDonnell C, Given FH, Keane PW: Analgesia in day case breast-biopsy - The value of pre-emptive tenoxicam. Can J Anaesth 1998; 45:217-22
32. O'Hanlan DM, Thambipillai T, Colbert ST, Keane PW, Given HF: Timing of pre-emptive tenoxicam is important for postoperative analgesia. Can J Anaesth 2001; 48:162-6
33. Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J: The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94:55-9
34. Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenberg AG: Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: A randomized controlled trial. JAMA 2003; 290:2411-8
35. Uda R, Horiguchi S, Ito S, Hyodo M, Hayashi I: Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res 1990; 510:26-32.
36. Vasquez E, Bär KJ, Ebersberger A, Klein B, Vanegas H, Schaible HG: Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci 2001; 21:9001-8
37. Mull-Selbach US, Tegeder I, Brune K, Geisslinger G: Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. ANESTHESIOLOGY 1999; 91:231-9
38. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinhold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, Wolfer DP, Betz H, Zeilhofer HU, Muller U: GlyR α3: An essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004; 7:884-7
39. Roszkowski MT, Swift JQ, Hargreaves KM: Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars. Pain 1997; 73:339-45
40. Khan AA, Brahim JS, Rowan JS, Dionne RA: In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Clin Pharm Ther 2002; 72:44-9
41. Woolf CJ, Chong MS: Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77:362-79
42. Girod V, Dapzol J, Bouvier M, Grelot L: The COX inhibitors indomethacin and meloxicam exhibit anti-emetic activity against cisplatin-induced emesis in piglets. Neuropharmacology 2002; 42:428-36
43. Cheng J-C, Siegel I, Katari B, Traynoff S, Ro J: Non-steroidal anti-inflammatory drugs and aspirin: A comparison of the anti platelet effect. Am J Ther 1997; 4:62-5